BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 52045)

  • 1. Letter: Disodium ethane-1-hydroxy-1, 1-diphosphonate(E.H.D.P.) in Paget's disease.
    Fromm G; Schajowicz F; Mautalen CA
    Lancet; 1975 Oct; 2(7936):666. PubMed ID: 52045
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
    de Vries HR; Bijvoet OL; Froeling PG
    J Endocrinol; 1975 Mar; 64(3):51P. PubMed ID: 805820
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Diphosphonate and calcitonin in Paget's disease.
    Hosking DJ; Bijvoet OL
    Lancet; 1976 May; 1(7966):970. PubMed ID: 57380
    [No Abstract]   [Full Text] [Related]  

  • 4. Paget's bone disease treated with diphosphonate and calcitonin.
    Hosking DJ; Bijvoet OL; van Aken J; Will EJ
    Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR; Bijvoet OL
    Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
    Hosking DJ; Bijvoet OL
    Calcif Tissue Res; 1976 Aug; 21 Suppl():321-6. PubMed ID: 821599
    [No Abstract]   [Full Text] [Related]  

  • 7. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
    Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
    Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR
    N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical, biological and histological effects of ethane-1-hydroxy 1, 1-diphosphonate (EDHP) in Paget's disease].
    Meunier P; Chapuy MC; Courpron P; Vignon E; Edouard C; Bernard J
    Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):699-705. PubMed ID: 817385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphosphonates in Paget's disease.
    Russell RG; Smith R; Preston C; Walton RJ; Woods CG
    Lancet; 1974 May; 1(7863):894-8. PubMed ID: 4133419
    [No Abstract]   [Full Text] [Related]  

  • 12. Radionuclide uptake studies of bone: a quantitative method of evaluating the response of patients with Paget's disease to diphosphonate therapy.
    Goldman AB; Braunstein P; Wilkinson D; Kammerman S
    Radiology; 1975 Nov; 117(2):365-9. PubMed ID: 809805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etidronate disodium for Paget's disease.
    Med Lett Drugs Ther; 1978 Sep; 20(18):78-9. PubMed ID: 99647
    [No Abstract]   [Full Text] [Related]  

  • 14. [Usefulness of ethane-hydroxy-diphosphonate in the treatment of Paget's disease].
    Morales Piga A; García Vadillo A; Rodríguez García A; Elena Ibáñez A; Castro Beiras JM; Rodríguez Torrás M
    Rev Clin Esp; 1985 Oct; 177(6):273-7. PubMed ID: 3936134
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evolution of Paget's disease of bone during and after treatment with small doses of disodium etidronate (EHDP)].
    Reginster JY; Gritten C; Diverse P; Hauwaert C; Halleux R; Franchimont P
    Rev Med Liege; 1985 May; 40(10):417-22. PubMed ID: 3927462
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 18. [Non-hormonal drug treatment in Paget's disease].
    Ryckewaert A; Lemaire V; Tubiana M
    Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):693-8. PubMed ID: 131365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of Paget's disease with 1-ethane-1-hydroxy-1-diphosphonate].
    Renier JC; Bontoux-Carre E; Bontoux L; Basle M; Moreau R; Jallet P
    Rev Rhum Mal Osteoartic; 1982 Feb; 49(2):87-92. PubMed ID: 6801754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate].
    Pinel B; Cambon C; Thomine JM; Cauvin M; Daragon A; Deshayes P
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):417-8. PubMed ID: 6436959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.